Protective Effect of Omega-7 against Doxorubicin-Induced Cardiotoxicity in Male Rats

Authors

  • Mohammed H. Fadhel Department of Pharmacology and Toxicology, College of Pharmacy, University of Baghdad, Baghdad, Iraq.
  • Ali F Hassan 1Department of Pharmacology and Toxicology, College of Pharmacy, University of Baghdad, Baghdad, Iraq.

DOI:

https://doi.org/10.31351/vol32iss3pp35-40

Abstract

Background: Doxorubicin is considered one of the most effective anticancer drugs, yet it is use is limited by its side effect mediated by the generation of reactive oxygen species. Omega-7, an antioxidant has shown to have a cardioprotective effect.

Aim of the study: evaluate a possible protective effect of omega-7 against doxorubicin-induced cardiotoxicity in male rats.

Methods: twenty-eight male rats were divided into 4 groups (7 for each group).  Group 1 (Negative control): healthy animals received normal saline orally as the vehicle for eight successive days and were sacrificed on day 9. Group 2 (positive control): animals that received a single dose of doxorubicin HCl (i.p 15mg/kg). Sacrificed the next day. Group 3: omega 7 was administered orally at a dose 100 mg/kg/day for eight days. On day 9, doxorubicin was administered IP (15mg/kg). Sacrificed on day 10. Group 4: omega 7 was administered orally at a dose 300 mg/kg/day for eight days. On day 9, doxorubicin was administered IP (15mg/kg) and sacrificed on day 10. Omega7 treatment started eight days before doxorubicin. The analysis was done on day 10.

 Results: In the present study, catalase, and glutathione peroxidase were significantly increased in the omega7 treated group when compared to the negative control group (p<0.05) at the same time, malondialdehyde and reactive oxygen species were significantly decreased in the omega7 treated group when compared to the negative control group (p<0.05).

Conclusion: this in vivo enzymatic study provides a piece of evidence for the possible effect of omega7 in the attenuation of cardiac toxicity in doxorubicin-treated patients

References

Wonders, K.Y., et al., Acute exercise protects against doxorubicin cardiotoxicity. Integrative Cancer Therapies, 2008. 7(3): p. 147-154.

Gandhi, H., et al., Doxorubicin mediated cardiotoxicity in rats: Protective role of felodipine on cardiac indices. Environmental toxicology and pharmacology, 2013. 36(3): p. 787-795.

Venditti, P., et al., Free radical involvement in doxorubicin-induced electrophysiological alterations in rat papillary muscle fibres. Cardiovascular research, 1998. 38(3): p. 695-702.

Shi, Y., et al., Mechanisms and management of doxorubicin cardiotoxicity. Herz, 2011. 36(4): p. 296-305.

Sheibani, M., et al., Cardioprotective effects ofdapsone against doxorubicin-induced cardiotoxicity in rats. Cancer chemotherapy and pharmacology, 2020. 85(3): p. 563-571.

Destaillats, F., et al., Vaccenic and rumenic acids, a distinct feature of ruminant fats. Journal of dairy science, 2005. 88(2): p. 449.

Mukherjee, K.D. and I. Kiewitt, Formation of (n-9) and (n-7) cis-monounsaturated fatty acids in seeds of higher plants. Planta, 1980. 149(5): p. 461-463.

Frigolet, M.E. and R. Gutiérrez-Aguilar, The role of the novel lipokine palmitoleic acid in health and disease. Advances in Nutrition, 2017. 8(1): p. 173S-181S.

Olson, R.D. and P.S. Mushlin, Doxorubicin cardiotoxicity: analysis of prevailing hypotheses. The FASEB journal, 1990. 4(13): p. 3076-3086.

Bernstein, A.M., M.F. Roizen, and L. Martinez, RETRACTED: Purified palmitoleic acid for the reduction of high-sensitivity C-reactive protein and serum lipids: A double-blinded, randomized, placebo controlled study. 2014, Elsevier.

Song, I.-B., et al., Omega-7 inhibits inflammation and promotes collagen synthesis through SIRT1 activation. Applied Biological Chemistry, 2018. 61(4): p. 433-439.

García, V.L., The omega 7 as a health strategy for the skin and mucous membranes. EC Nutr, 2019. 14: p. 484-489.

Nagi, M.N. and M.A. Mansour, Protective effect of thymoquinone against doxorubicin–induced cardiotoxicity in rats: A possible mechanism of protection. Pharmacological research, 2000. 41(3): p. 283-289.

Al-Shawi, N.N., Possible Protective Effects of high-versus low-dose of lutein in combination with irinotecan on Liver of Rats: Role of Oxidative Stress and Apoptosis. Indian Journal of Forensic Medicine & Toxicology, 2021. 15(1).

Lampl, T., et al., Isolation and functional analysis of mitochondria from cultured cells and mouse tissue. JoVE (Journal of Visualized Experiments), 2015(97): p. e52076.

Gagné, F., Tissue preparation and subcellular fractionation techniques. Biochemical Ecotoxicology; Elsevier: Amsterdam, The Netherlands, 2014: p. 21-31.

Ridha, D.K.A. and N.N. Al-Shawi, The Impacts of Graded Doses of Pyridoxine on the Biomarkers, Aspartate Aminotransferase, lactate Dehydrogenase and Total Antioxidant Capacity in Doxorubicin-Induced Cardiotoxicity in Female Rats. Iraqi Journal of Pharmaceutical Sciences (P-ISSN: 1683-3597, E-ISSN: 2521-3512), 2017: p. 12-21.

Abdulrazzaq, M.H., Protective effect of benfotiamine against doxorubicin-induced cardiotoxicity in rabbits. Iraqi Journal of Pharmaceutical Sciences (P-ISSN: 1683-3597, E-ISSN: 2521-3512), 2007. 16(1): p. 14-17.

Iqbal, M., et al., Protective effects of telmisartan against acute doxorubicin-induced cardiotoxicity in rats. Pharmacological reports, 2008. 60(3): p. 382.

Downloads

Published

2023-12-29